and (b) data for metabolites, co-factors, genes and/or enzymes associated with the -glutamyl cycle or the trans-sulphuration pathway, and/or (c) interventions using metabolites or cofactors of the -glutamyl cycle or the trans-sulphuration pathway
Liraglutide 3.0 mg weekly or 1.8 mg daily was the only GLP-1 receptor agonist in the network that achieved significant weight reduction without significantly reducing lean mass
Allergy-wise, curcumin is a documented (but uncommon) contact allergen
Which bypass some first-pass hepatic metabolism
It's safe, effective, and requires minimal downtime compared to other chemical peels of similar strength
The OASIS 4 double-blind, randomised controlled trial of oral semaglutide 25 mg daily was published in the same issue of the New England Journal of Medicine (Wharton et al, 2025b)